BioCentury | Feb 23, 2015
Emerging Company Profile

Eyeing new antibiotics

...by inhibiting protein, DNA, or cell wall synthesis but require multiplying cells to be effective. SinSa Laboratories...
...NASDAQ:DPRX), New York, N.Y. Lytix Biopharma A/S , Tromso, Norway Singapore Eye Research Institute, Singapore SinSa Laboratories Inc....
...highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections." Journal of Medicinal Chemistry (2015) Sidebars SinSa Laboratories Inc....
BioCentury | Jan 22, 2015
Distillery Therapeutics

Therapeutics: Unknown

...testing to confirm oral bioavailability. TARGET/MARKER/PATHWAY: Unknown LICENSING STATUS: Patents issued and pending; licensed to Sinsa Labs...
BioCentury | Jan 22, 2015
Targets & Mechanisms

Unearthing antibiotics

...Calif. Northeastern University, Boston, Mass. NovoBiotic Pharmaceuticals LLC, Cambridge, Mass. Singapore Eye Research Institute, Singapore Sinsa Labs...
Items per page:
1 - 3 of 3
BioCentury | Feb 23, 2015
Emerging Company Profile

Eyeing new antibiotics

...by inhibiting protein, DNA, or cell wall synthesis but require multiplying cells to be effective. SinSa Laboratories...
...NASDAQ:DPRX), New York, N.Y. Lytix Biopharma A/S , Tromso, Norway Singapore Eye Research Institute, Singapore SinSa Laboratories Inc....
...highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections." Journal of Medicinal Chemistry (2015) Sidebars SinSa Laboratories Inc....
BioCentury | Jan 22, 2015
Distillery Therapeutics

Therapeutics: Unknown

...testing to confirm oral bioavailability. TARGET/MARKER/PATHWAY: Unknown LICENSING STATUS: Patents issued and pending; licensed to Sinsa Labs...
BioCentury | Jan 22, 2015
Targets & Mechanisms

Unearthing antibiotics

...Calif. Northeastern University, Boston, Mass. NovoBiotic Pharmaceuticals LLC, Cambridge, Mass. Singapore Eye Research Institute, Singapore Sinsa Labs...
Items per page:
1 - 3 of 3